GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3476 - 3500 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▲ Arbitrary Fluorescence Units (AFU)
IgM Patient 3 11 mild
G84224TW
388
IgM Patient 3 4 mild
G84224TW
332
IgA Patient 4 12 mild
G84224TW
555
IgG Patient 4 12 mild
G84224TW
110
IgM Patient 4 12 mild
G84224TW
357
IgA Patient 1 10 moderate
G86156UJ
311
IgA Patient 1 22 moderate
G86156UJ
438
IgA Patient 1 6 moderate
G86156UJ
448
IgG Patient 1 10 moderate
G86156UJ
50
IgG Patient 1 22 moderate
G86156UJ
75
IgM Patient 1 10 moderate
G86156UJ
48
IgM Patient 1 22 moderate
G86156UJ
190
IgA Patient 2 15 mild
G86156UJ
450
IgA Patient 2 24 mild
G86156UJ
544
IgG Patient 2 15 mild
G86156UJ
11027
IgG Patient 2 24 mild
G86156UJ
11808
IgM Patient 2 15 mild
G86156UJ
284
IgG Patient 1 6 moderate
G86156UJ
59
IgM Patient 1 6 moderate
G86156UJ
48
IgA Patient 2 3 mild
G86156UJ
672
IgG Patient 2 3 mild
G86156UJ
22997
IgM Patient 2 24 mild
G86156UJ
331
IgM Patient 2 3 mild
G86156UJ
527
IgA Patient 3 -180 mild
G86156UJ
256
IgA Patient 3 11 mild
G86156UJ
442

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024